A Study to Evaluate the Accuracy of a Breast Cancer Locator (BCL) in Patients With Palpable Cancers
Completed · Not applicable
Conditions studied: Breast Cancer
In brief
In this study, the investigators will enroll women with palpable cancers to assess the accuracy of the Breast Cancer Locator (BCL) and the concomitant procedure as a vehicle to optimize and validate the approach in such surgical cases. This approach of adopting palpable cancer patients before initiating an evaluative trial of the BCL in non-palpable breast cancer cases ensures that the BCL does not substantially alter or modify the standard-of-care procedure.
Key facts
- Study ID
- NCT02550210
- Run by
- Dartmouth-Hitchcock Medical Center
- People needed
- 23
- Starts
- 2015-08-01
- Expected to finish
- 2018-02-01
- Last updated by the study team
- 2019-04-30
Who can join
Age: 18 and older, up to 99. Sex: female. Healthy volunteers: not accepted.
You may qualify if…
- Age greater than or equal to 18 years
- Histologic diagnosis of palpable invasive breast cancer or ductal carcinoma in situ
- Patient desire to undergo breast surgery
- Ability to voluntarily provide informed consent to participate prior to any study-related assessments/procedures being conducted
- The cancer enhances on breast MRI imaging.
You may not qualify if…
- Absolute contraindication to MRI, including presence of implanted electrical device (pacemaker or neurostimulator), aneurysm clip, or metallic foreign body in or near eyes
- Severe claustrophobia
- Contraindication to use of gadolinium-based intravenous contrast, including life-threatening allergy or compromised renal function (creatinine > 2.0)
- History of median sternotomy
- Pregnancy. Patient attestation that they are not pregnant will be acceptable as per standard policy for MRIs at DHMC.
Where it is running
- Dartmouth Hitchcock Medical Center — Lebanon, New Hampshire, United States
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.